Cognitex supplementation in elderly adults with memory complaints: an uncontrolled open label trial.
about
Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.From Age-Related Cognitive Decline to Alzheimer's Disease: A Translational Overview of the Potential Role for Phosphodiesterases.
P2860
Cognitex supplementation in elderly adults with memory complaints: an uncontrolled open label trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cognitex supplementation in el ...... uncontrolled open label trial.
@en
type
label
Cognitex supplementation in el ...... uncontrolled open label trial.
@en
prefLabel
Cognitex supplementation in el ...... uncontrolled open label trial.
@en
P2093
P2860
P1476
Cognitex supplementation in el ...... uncontrolled open label trial.
@en
P2093
Inbal Eyal
Tzafra Cohen
Yael Herzog
Yael Richter
P2860
P304
P356
10.3109/19390211.2011.569514
P407
P577
2011-06-01T00:00:00Z